SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ishita Drugs & Industries appoints director

28 Jan 2013 Evaluate

Ishita Drugs & Industries has informed that Niranjan Agrawal has been appointed as a non-executive, independent director on the board of directors of the company w.e.f. January 25, 2013.

The above information is a part of company’s filings submitted to BSE.

Ishita Drugs & Inds. Share Price

77.00 0.94 (1.24%)
20-Apr-2026 15:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.00
Dr. Reddys Lab 1230.30
Cipla 1228.30
Zydus Lifesciences 936.80
Lupin 2326.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×